Integrated Advisors Network’s Regeneron Pharmaceuticals REGN Stock Holding History

Integrated Advisors Network’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$639K	Buy	+828	New	+$634K	0.03%	415
2024 Q4	–	Sell	-197	Closed	-$207K	–	750
2024 Q3	$207K	Sell	197 -11	-5%	-$12.2K	0.01%	682
2024 Q2	$218K	Sell	208 -3	-1%	-$2.91K	0.01%	642
2024 Q1	$203K	Sell	211 -46	-18%	-$43.7K	0.01%	685
2023 Q4	$225K	Sell	257 -17	-6%	-$14K	0.01%	615
2023 Q3	$225K	Buy	+274	New	+$215K	0.01%	603
2023 Q2	–	Sell	-260	Closed	-$213K	–	703
2023 Q1	$213K	Buy	+260	New	+$196K	0.01%	615
2020 Q4	–	Sell	-1,121	Closed	-$628K	–	514
2020 Q3	$628K	Buy	1,121 +545	+95%	+$330K	0.08%	223
2020 Q2	$359K	Buy	+576	New	+$327K	0.04%	309

Other funds holding REGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Integrated Advisors Network's REGN Position: Q1 2026 in Review

Integrated Advisors Network opened a new position in Regeneron Pharmaceuticals (REGN) in Q1 2026: 828 shares worth $639K. The stake represents 0.03% of the portfolio and ranks #415 among its holdings. This is a return to the name: Integrated Advisors Network previously reported a position in REGN as recently as Q3 2024.

Integrated Advisors Network first reported a position in REGN in Q2 2020 and has held it in 9 quarters since. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

Integrated Advisors Network held 828 shares of Regeneron Pharmaceuticals worth $639K as of Q1 2026.
Regeneron Pharmaceuticals was a new Integrated Advisors Network position in Q1 2026.
Regeneron Pharmaceuticals made up 0.03% of Integrated Advisors Network's portfolio in Q1 2026, its #415 holding.
Integrated Advisors Network first reported a position in Regeneron Pharmaceuticals in Q2 2020 and has held it in 9 quarters since.
1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Integrated Advisors Network's 13F filing for Q1 2026, filed 28 Apr 2026.